FORA Capital’s Neuronetics STIM Stock Holding History

FORA Capital’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,483	Closed	-$42.3K	–	682
2025 Q1	$42.3K	Buy	+11,483	New	+$41.9K	﹤0.01%	483

Other funds holding STIM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

FORA Capital's STIM Position: Q2 2025 in Review

FORA Capital sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 11,483 shares — an estimated $42.3K sold.

FORA Capital first reported a position in STIM in Q1 2025 and held it in 1 quarter. The position peaked at $42.3K in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

FORA Capital reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
FORA Capital sold 11,483 Neuronetics shares in Q2 2025, an estimated $42.3K.
FORA Capital first reported a position in Neuronetics in Q1 2025 and held it in 1 quarter.
FORA Capital's Neuronetics position peaked at $42.3K in Q1 2025.
90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.